Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
25-<50 10-<25
EC/CAS
219-784-2/2530-83-8
Name of the chemical
[3-(2,3-epoxypropoxy)propyl]trimethoxy silane
Concentration
2.5-<10
EC/CAS
204-658-1/123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
1.0-<2.5
EC/CAS
247-714-0/68299-15-0
Name of the chemical
Dioctyltindineodecanoate
Concentration
0.1-<1.0
EC/CAS
205-480-7/77-99-6
Name of the chemical
1,1,1-trimethylolpropane
Concentration
0.1-<1.0
EC/CAS
205-480-7/141-32-2
Name of the chemical
acrylic acid, n-butyl ester
Concentration
0.1 - <1.0
General Information
Version
6
Revision date
2023-10-07
Product name
8670
supplier name
Tarka, Malgorzata
Manufacturer Name
Carboline Norge AS
Emergency telephone
+1 703 5273887 (Outside US
Icons in SDS
Company Information
company name
Carboline Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
hms@carboline.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H318, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Hazard statements
Skin Cracking EUH066 Skin Sens. 1 H317 Eye Dam. 1 H318 Aquatic Chronic 3 H412 Skin Cracking EUH066 Repeated exposure may cause skin dryness or cracking. EU Other EUH211 Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist. Skin Sens. 1 H317 May cause an allergic skin reaction. Eye Dam. 1 H318 Causes serious eye damage. Aquatic Chronic 3 H412 Harmful to aquatic life with long lasting effects.
2.2 Label elements
Symbol(s) of Product
Signal word
Danger Named Chemicals on Label [3-(2,3-epoxypropoxy)propyl]trimethoxysilane, Reaction mass of bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate and methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate
2.3 Other hazards
No Information
Results of PBT and vPvB assessment
The product does not meet the criteria for PBT/vPvB in accordance with Annex XIII. Endocrine disrupting properties - Toxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher. Endocrine disrupting properties - Ecotoxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher.
